MedPath

Our experience in the usage of thoracic epidural analgesia in patients donating the liver for transplant purpose

Not Applicable
Completed
Conditions
Health Condition 1: null- patient undergoing donor hepatectomy
Registration Number
CTRI/2016/09/007247
Lead Sponsor
Sir Ganga Ram Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
120
Inclusion Criteria

patients undergoing donor hepatectomy

Exclusion Criteria

age less than 18 years

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate the safety of thoracic epidural analgesia in terms of <br/ ><br>1. quality of post operative analgesia <br/ ><br>2. changes in coagulation profile in post operative period and timing of removal of epidural catheter <br/ ><br>3. Incidence of epidural catheter related complicationsTimepoint: 1. Entire intraoperative period <br/ ><br>2. Post operatively everyday until epidural catheter removal <br/ ><br>
Secondary Outcome Measures
NameTimeMethod
1. Effect of thoracic epidural analgesia on intraoperative haemodynamic parameters, central venous pressure <br/ ><br>2.assessing whether duration of surgery, volume infused, residual liver volume and hypocalcemia increase the risk of coagulopathy in these patientsTimepoint: day 1, 2, 3, 4, 5
© Copyright 2025. All Rights Reserved by MedPath